226 related articles for article (PubMed ID: 16318611)
21. Current trends in cervical ripening and labor induction.
Harman JH; Kim A
Am Fam Physician; 1999 Aug; 60(2):477-84. PubMed ID: 10465223
[TBL] [Abstract][Full Text] [Related]
22. Abruptio placentae associated with misoprostol use in women with preeclampsia.
Fontenot MT; Lewis DF; Barton CB; Jones EM; Moore JA; Evans AT
J Reprod Med; 2005 Sep; 50(9):653-8. PubMed ID: 16363752
[TBL] [Abstract][Full Text] [Related]
23. Induction of labour: a comparison between controlled-release dinoprostone vaginal pessary (Cervidil) and dinoprostone intravaginal gel (Prostin E2).
Kho EM; Sadler L; McCowan L
Aust N Z J Obstet Gynaecol; 2008 Oct; 48(5):473-7. PubMed ID: 19032662
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness and safety of a new vaginal misoprostol product specifically labeled for cervical ripening and labor induction.
Cecatti JG; Tedesco RP; Pires HM; Calderon IM; Faúndes A
Acta Obstet Gynecol Scand; 2006; 85(6):706-11. PubMed ID: 16752263
[TBL] [Abstract][Full Text] [Related]
25. Comparative analysis of the effectiveness of misoprostol and prostaglandin E(2) in the preinduction and induction of labor.
Leszczyńska-Gorzelak B; Laskowska M; Oleszczuk J
Med Sci Monit; 2001; 7(5):1023-8. PubMed ID: 11535953
[TBL] [Abstract][Full Text] [Related]
26. Effect of vaginal pH on efficacy of the controlled-release dinoprostone vaginal insert for cervical ripening/labor induction.
Ramsey PS; Ogburn PL; Harris DY; Heise RH; DiMarco CS; Ramin KD
J Matern Fetal Neonatal Med; 2003 Apr; 13(4):250-3. PubMed ID: 12854926
[TBL] [Abstract][Full Text] [Related]
27. Vaginal misoprostol for cervical ripening at term: comparison of outpatient vs. inpatient administration.
Chang DW; Velazquez MD; Colyer M; Klaus P; Mallipeddi SK; Rayburn WF
J Reprod Med; 2005 Oct; 50(10):735-9. PubMed ID: 16320553
[TBL] [Abstract][Full Text] [Related]
28. The risk of placental abruption when using prostaglandins for cervical ripening in women with preeclampsia: comparing misoprostol versus dinoprostone.
Martinez de Tejada B; Martillotti G; Lapaire O; Hoesli I; Irion O
J Matern Fetal Neonatal Med; 2010 Sep; 23(9):988-93. PubMed ID: 19941444
[TBL] [Abstract][Full Text] [Related]
29. Sustained-release dinoprostone vaginal pessary with concurrent high-dose oxytocin infusion compared to sustained-release dinoprostone vaginal pessary followed 6 h later by high-dose oxytocin infusion for labor induction in women at term with unfavorable cervix: a randomized controlled trial.
Güngördük K; Yildirim G; Güngördük O; Ark C; Tekirdağ I
Gynecol Obstet Invest; 2011; 71(1):32-40. PubMed ID: 21160192
[TBL] [Abstract][Full Text] [Related]
30. [Evidence-based medicine: labor induction with prostaglandins].
Winkler M; Rath W
Z Geburtshilfe Neonatol; 1999 Dec; 203 Suppl 2():6-11. PubMed ID: 10612191
[TBL] [Abstract][Full Text] [Related]
31. Intravaginal glyceryl trinitrate and dinoprostone for cervical ripening and induction of labor.
Nunes FP; Campos AP; Pedroso SR; Leite CF; Avillez TP; Rodrigues RD; Meirinho M
Am J Obstet Gynecol; 2006 Apr; 194(4):1022-6. PubMed ID: 16580291
[TBL] [Abstract][Full Text] [Related]
32. [Pharmacological induction of labour: benefits and risks].
Romanelli M; Ribiani E; Burnelli L; Luzi G; Affronti G; Di Renzo GC
Minerva Ginecol; 2007 Aug; 59(4):347-55. PubMed ID: 17923826
[TBL] [Abstract][Full Text] [Related]
33. Titrated oral compared with vaginal misoprostol for labor induction: a randomized controlled trial.
Cheng SY; Ming H; Lee JC
Obstet Gynecol; 2008 Jan; 111(1):119-25. PubMed ID: 18165400
[TBL] [Abstract][Full Text] [Related]
34. Outpatient cervical ripening using a sustained-release prostaglandin E2 vaginal insert.
Tassone SA; Pearman CR; Rayburn WF
J Reprod Med; 2001 Jun; 46(6):599-600. PubMed ID: 11441687
[TBL] [Abstract][Full Text] [Related]
35. Methods for cervical ripening and induction of labor.
Tenore JL
Am Fam Physician; 2003 May; 67(10):2123-8. PubMed ID: 12776961
[TBL] [Abstract][Full Text] [Related]
36. Retention of dinoprostone vaginal insert beyond 12 hours for induction of labor.
Brennan MC; Pevzner L; Wing DA; Powers BL; Rayburn WF
Am J Perinatol; 2011 Jun; 28(6):479-84. PubMed ID: 21225563
[TBL] [Abstract][Full Text] [Related]
37. Cardiotocographic abnormalities associated with dinoprostone and misoprostol cervical ripening.
Ramsey PS; Meyer L; Walkes BA; Harris D; Ogburn PL; Heise RH; Ramin KD
Obstet Gynecol; 2005 Jan; 105(1):85-90. PubMed ID: 15625147
[TBL] [Abstract][Full Text] [Related]
38. Induction of labour at term with vaginal prostaglandins preparations: a randomised controlled trial of Prostin vs Propess.
El-Shawarby SA; Connell RJ
J Obstet Gynaecol; 2006 Oct; 26(7):627-30. PubMed ID: 17071427
[TBL] [Abstract][Full Text] [Related]
39. Comparing two dinoprostone agents for cervical ripening and induction of labor: a randomized trial.
Marconi AM; Bozzetti P; Morabito A; Pardi G
Eur J Obstet Gynecol Reprod Biol; 2008 Jun; 138(2):135-40. PubMed ID: 17889983
[TBL] [Abstract][Full Text] [Related]
40. Pre-induction cervical ripening using two different dinoprostone vaginal preparations: A randomized clinical trial of tablets and slow release retrievable insert.
Abdelaziz A; Mahmoud AA; Ellaithy MI; Abees SH
Taiwan J Obstet Gynecol; 2018 Aug; 57(4):560-566. PubMed ID: 30122579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
